logo-loader
NASDAQ:ADAP

Adaptimmune Therapeutics PLC

Receive alerts
Market:
NASDAQ
Market Cap:
$463.64 m
Price
3.58 USD
Change
-4.53%
52 weeks high
6.00
52 weeks low
0.71

In brief

Adaptimmune is a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapy products for cancer patients.